CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 85 enrolled
Drug / intervention
Mechanical Thrombectomy by the Indigo Systemdevice
Likely dose
Mechanical thrombectomy via Indigo SystemAI-extracted
Key inclusion· 2
  • Evidence of peripheral or visceral arterial occlusion or embolus with TIMI 0-1 flow prior to treatment
  • Treated with components of Penumbra and/or Indigo System
Key exclusion· 1
  • Concurrent participation in another clinical investigation that may confound results

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02085551
NCT02085551N/ACompleted

The Prism Trial: A Retrospective Case Review of Technical Success Using the Penumbra and Indigo Systems for Mechanical Thrombectomy in the Periphery

Penumbra Inc.·interventional·Posted Mar 13, 2014·Updated Jun 22, 2020

In Brief

A clinical study evaluating Mechanical Thrombectomy by the Indigo System for Peripheral Arterial Occlusion or Emboli. Completed, enrolled 85 participants across 5 sites.

Detailed Summary

The primary objective of this retrospective case review study is to determine the safety and effectiveness of the Penumbra and Indigo Systems for mechanical thrombectomy in a cohort of patients with confirmed peripheral or visceral arterial occlusion or embolus. This is a retrospective, single arm, multi-center trial. Up to 100 patients at up to 10 centers will be enrolled. Angiographic assessment of vessel patency at immediate post-procedure as measured by TIMI scores and procedural serious adverse events are assessed and recorded.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedMar 13, 2014
Enrollment StartMar 1, 2014
Primary CompletionSep 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 12.3 years ago

Interventions

Mechanical Thrombectomy by the Indigo Systemdevice